Theme: “New Scientific Discoveries and Technologies in Dementia Research"



Me Conferences cordially invites all participants from around the world to attend the '17th Annual Conference on Dementia and Alzheimer's Disease' on December 05-06, 2022 in Rome, Italy which will feature timely keynote presentations, workshops, special sessions, exhibitors, poster presentations, and oral presentations. Conference will be organized under the theme “New Scientific Discoveries and Technologies in Dementia Research"

All stakeholders working on Alzheimer's disease and dementia will be able to discuss new findings at the Dementia Conference 2022. Dementia Conference 2022 is expected to bring together important speakers, neurologists, and dementia researchers from academia and the health-care business to share their perspectives and research. The conference will feature sessions led by world-class experts in the field of neurology. International symposiums, B2B conferences, and international workshops will be held during the dementia Conference 2022 to discuss specific subjects in the field of dementia and Alzheimer's disease.

Target Audience:

  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Specialists
  • Researchers
  • Health care professionals
  • Professors
  • Industrial Experts
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Scientists
  • Lecturers and Students from Academia in the study of Dementia
  • Students from Academia in the research of Neurology

Track 1: Dementia

Dementia is a wide term for a group of brain illnesses that cause a long-term, typically gradual decline in a person's capacity to think and remember to the point where it interferes with daily activities. Emotional issues, language difficulties, and a lack of motivation are all prevalent signs. The consciousness of a person is frequently unaffected. Dementia causes a shift in a person's normal mental functioning as well as a faster decrease than one would expect from age. These disorders have a tremendous impact on the carers of those who are afflicted.

Track 2: Alzheimers Disease

Alzheimer's disease (AD), generally known as Alzheimer's, is a progressive neurological disease that begins slowly and worsens with time. It is responsible for 60 to 70 percent of dementia cases. The most prevalent early sign is short-term memory loss, or the inability to recall recent events. [As the condition progresses, symptoms may include linguistic difficulties, disorientation (including the ability to quickly become lost), mood changes, loss of motivation, inability to manage self-care, and behavioural problems. When a person's health deteriorates, they frequently retreat from family and society. Bodily functions gradually deteriorate, eventually leading to death.

Track 3: Schizophrenia

Schizophrenia is a long-term brain illness that affects around 1% of the population. Symptoms of schizophrenia include delusions, hallucinations, difficulty thinking and concentrating, and a lack of motivation. When these symptoms are addressed, however, most persons with schizophrenia will notice a significant improvement over time.

Track 4: Neurodegenerative Diseases

Your brain and nerves degenerate over time as a result of neurodegenerative illnesses. They have the potential to alter your personality and cause confusion. They can also damage the cells and nerves in your brain. Alzheimer's disease, for example, is a type of brain disease that can develop as you become older. They can wreak havoc on your memory and mental processes over time. Other diseases, such as Tay-Sachs disease, are inherited and manifest themselves at a young age.

Track 5: Psychiatry Mental Health Disorders

Physical symptoms such as a headache, back discomfort, or stomach pain may be caused by a psychological condition. If you're being screened for a psychiatric issue, notify your doctor if you're experiencing any physical symptoms, such as inexplicable aches and pains. Mental health nursing, often known as psychiatry nursing, is a branch of nursing that provides care to persons of all ages who are suffering from mental illnesses such as schizophrenia, bipolar disorder, depression, or psychosis. It is both a difficult and emotionally exhausting profession and a rewarding job for a single career.

Track 6: Parkinson’s Diseases

Parkinson's disease (PD) is a chronic and progressive movement illness, which means that symptoms develop over time and worsen. Parkinson's disease affects nearly one million people in the United States. Although there is currently no cure, there are therapeutic options available, including medication and surgery, to manage the symptoms

Track 7: Anxiety & Depression

People with dementia frequently suffer from apathy, despair, and worry. Because they might impair a person's emotional and mental health, they are referred to as psychological conditions. Anxiety is defined as a state of mind that is more than just concerned or worried. Anxious sensations are a natural reaction to being under pressure, and they normally subside once the stressful circumstance has gone or the'stressor' has been removed. Depression has an impact on a person's self-esteem. A person's interest in work, hobbies, and activities that he or she ordinarily enjoys may wane. Some people may be tired, have trouble sleeping, or sleep more than they should, while others may be nervous or angry, and find it difficult to focus.

Track 8: Animal Models in Dementia

Animal models have made a significant contribution to these advancements and are an essential component in the evaluation of treatments. This paper offers a thorough examination of animal models of dementia and cognitive impairment. A comprehensive study of dementia and Alzheimer's disease was conducted, as well as a critical evaluation of current rat models of dementia and a discussion of their importance in medication discovery and development.

Track 9: Diagnosis of Dementia

Determining the type of dementia and diagnosing it might be difficult. At least two essential brain processes must be damaged to the point of interfering with daily activities in order to be diagnosed with dementia. Memory, linguistic abilities, ability to focus and pay attention, reasoning, problem-solving, and visual perception are among them.

Track 10: Dementia Management

Because dementia has no cure, the main goals of treatment are to maintain quality of life, improve cognition, mood, and behaviour. Promotes a secure environment Encourages social interaction. Treatment of cognitive symptoms, behavioural symptom management, pharmaceutical and non-pharmacological treatments, and dementia-friendly environments.

Track 11: Drug Development in Dementia

Dementia is defined as a progressive, permanent deterioration in cognition that affects a patient's pre-existing level of functioning. There are various aetiologies for dementia, the most common of which is Alzheimer's disease (AD). Drug development for Alzheimer's disease is based on a growing body of knowledge about the disease's pathophysiology. Targeting amyloid processing, tau aggregation, insulin signalling, neuroinflammation, and neurotransmitter dysfunction are among the disease-modifying techniques now being pursued, with mixed results. The amyloid cascade is crucial to several developing therapeutic approaches, reflecting its dominance on the pathophysiological stage.

Track 12: Recent Advancement in Treatments of Dementia                     

Epidemiological studies predict that the number of people aged 65 and up will rise dramatically in the next decades, with a significant proportion of this population developing dementia. Regardless of cognitive status, there is ample evidence that ageing is connected with a high rate of unpleasant disorders. As a result, the number of dementia patients who suffer from unpleasant illnesses is anticipated to rise.

Track 13: Clinical Trials & Case Reports in Dementia

The purpose of a lot of dementia research is to come up with methods for 'therapy' or even 'cure.' In dementia, the traditional bench to bedside approach has proven to be ineffective. There is a long list of prospective dementia treatment chemicals that have had promising preclinical and early phase trial results but have been found to be neutral or even detrimental in phase III investigations. Lewy body dementia is a prevalent but underdiagnosed type of dementia that is commonly confused with the more well-known Alzheimer's disease. The distinction is crucial in clinical practise because it might have significant management implications. The diagnosis of Lewy body dementia has far-reaching consequences.

Track 14: Public Health Nursing

The science of protecting the security and improving the health of communities via education, politics, and analysis for wellness and injury prevention is known as public health. For each individual, the term "public health" has a different meaning. There is a place for you in the field of public health, whether you want to crunch figures, do laboratory or field analysis, design policy, or work directly with people to help them improve their health. Being a public professional allows you to make a difference all over the world, solve community-wide health challenges, and influence policies that affect society's health.

Track 15: Neurocardiology and Strokes

A "brain attack" is referred to as a stroke. It can happen to anyone at any moment when there is a lack of blood supply to a specific part of the brain, resulting in cell death. When this happens, brain cells lose their oxygen supply and begin to die. When brain cells die during a stroke, abilities such as memory and muscular control are lost in that area of the brain.


To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 20-20, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View